⌘K

Login Start Free

Home/Insiders/Matis Louis

ML

SEC Insider//CIK 0001650991

Matis Louis

CIK 00016509911 companyFREISING-WEIHENSTEPHAN, 2M

Transactions

6

Companies

1

Filings

5

CIK

0001650991

Recent Transactions

6 trades

Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (Right to Buy)
2019-02-26+96,500→ 96,500 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Options (Right to buy)
2018-02-20+100,000→ 100,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock option (Right to buy)
2017-02-23+145,000→ 145,000 total
Purchase
PALVELLA THERAPEUTICS, INC.$PVLA
Common Stock
2016-06-14$1.71/sh+7,915→ 10,000 total
Purchase
PALVELLA THERAPEUTICS, INC.$PVLA
Common Stock
2016-06-13$1.68/sh+2,085→ 2,085 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Common Stock
2015-08-17+500,000→ 500,000 total

Companies

1

PALVELLA THERAPEUTICS, INC.
SVP, Chief Development Officer
$PVLA

Recent Filings

5

Address

C/O PIERIS PHARMACEUTICALS, INC. LISE-MEITNER-STRASSE 30

FREISING-WEIHENSTEPHAN, 2M, 85354

View on SEC.gov